Edwards Lifesciences Share Price (NYSE: EW)

$81.36

▲

0.13

(0.16%)

Last updated on August 30, 2025 at 1:29 am IST

$₹

Check the interactive Edwards Lifesciences Stock chart to analyse performance

Edwards Lifesciences stock performance

as on August 30, 2025 at 1:29 am IST

Today's Low:$80.74
Today's High:$81.51
$81.36
0.76%
Downside
Day's Volatility :0.94%
Upside
0.18%
52 Weeks Low:$64.01
52 Weeks High:$83.00
$81.36
21.33%
Downside
52 Weeks Volatility :22.89%
Upside
1.98%

Edwards Lifesciences Stock Returns

Period	Edwards Lifesciences Corp.	Sector (Health Care)	Index (Russel 2000)
3 Months	4.15%	3.6%	0.0%
6 Months	13.94%	-7.7%	0.0%
1 Year	18.31%	-12.6%	0.0%
3 Years	-8.29%	8.4%	-3.0%

Edwards Lifesciences Corp. Key Stats

Check Edwards Lifesciences key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close	$81.23
Open	$81.23
Today's High	$81.51
Today's Low	$80.74
Market Capitalization	$47.8B
Today's Volume	$2.7M
52 Week High	$83.0
52 Week Low	$64.005
Revenue TTM	$5.7B
EBITDA	$1.7B
Earnings Per Share (EPS)	$2.39
PE Ratio	34.03
Profit Margin	72.96%
Quarterly Earnings Growth YOY	-0.07%
Return On Equity TTM	15.53%

Stock Returns calculator for Edwards Lifesciences Stock including INR - Dollar returns

The Edwards Lifesciences stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Edwards Lifesciences investment value today

Current value as on today

₹1,23,461

Returns

₹23,461

(+23.46%)

Returns from Edwards Lifesciences Stock

₹18,342 (+18.34%)

Dollar Returns*

₹5,119 (+5.12%)

Indian investors sentiment towards Edwards Lifesciences Stock

-14%

Period: Aug 1, 2025 to Aug 31, 2025. Change in 30 Days versus previous period

Search interest for Edwards Lifesciences Stock from India on INDmoney has decreased by -14% in the last 30 days, reflecting a downward trend in search activity.

Indian Mutual Funds that invest in Edwards Lifesciences Stock

Name	Shares Held	Change in Shares	% of Assets
Motilal Oswal S&P 500 Index Fund Direct Growth	4742	23.09	0.09%

Global Institutional Holdings in Edwards Lifesciences Corp.

Name
Holdings %
Name
Holdings %
Vanguard Group Inc
11.92%
BlackRock Inc
9.32%
State Street Corp
4.39%
JPMorgan Chase & Co
3.74%
Wellington Management Company LLP
3.38%
Bank of New York Mellon Corp
3.01%

Analyst Recommendation on Edwards Lifesciences Stock

Rating

Trend

Buy

60%Buy

35%Hold

5%Sell

Based on 40 Wall street analysts offering stock ratings for Edwards Lifesciences(by analysts ranked 0 to 5 stars)

Edwards Lifesciences Share Price Target

What analysts predicted

Upside of 7.61%

Target:

$87.55

Current:

$81.36

Edwards Lifesciences share price target is $87.55, a slight Upside of 7.61% compared to current price of $81.36 as per analysts' prediction.

Edwards Lifesciences Stock Insights

Price Movement
In the last 6 months, EW stock has moved up by 13.6%
Increasing Revenue
Edwards Lifesciences Corp. has shown consistent revenue growth over the past four quarters, increasing from $1.35 billion to $1.53 billion. This represents an average quarterly increase of 4.0%.
Decreasing Net Profit
Edwards Lifesciences Corp. has experienced a decline in net profit over the last four quarters. The profit dropped significantly from $3.07 billion to $329.8 million, averaging a decrease of 34.2% each quarter.
EW vs BSX (1 yr)
In the last 1 year, Boston Scientific Corp. has given 29.0% return, outperforming this stock by 12.7%
EW vs BSX (3 yr)
In the last 3 years, Boston Scientific Corp. has given 157.4% return, outperforming this stock by 167.1%
Price to Sales
Edwards Lifesciences Corp. has a Price-to-Sales (P/S) Ratio of 8.4, meaning that for every $1 of sales, investors are willing to pay $8.4. This is the same P/S Ratio as Boston Scientific Corp., indicating that investors value both companies equally based on their sales performance.

Edwards Lifesciences Corp. Financials

Revenue

Profit

Cash Flow

Annually

Quarterly

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Revenue	$4.3B	↑ 16.79%
Net Income	$1.0B	↑ 44.96%
Net Profit Margin	24.08%	↑ 4.68%

	FY20	Y/Y Change
Revenue	$4.4B	↑ 0.88%
Net Income	$823.4M	↓ 21.35%
Net Profit Margin	18.77%	↓ 5.31%

	FY21	Y/Y Change
Revenue	$5.2B	↑ 19.29%
Net Income	$1.5B	↑ 82.55%
Net Profit Margin	28.73%	↑ 9.96%

	FY22	Y/Y Change
Revenue	$5.4B	↑ 2.86%
Net Income	$1.5B	↑ 1.25%
Net Profit Margin	28.28%	↓ 0.45%

	FY23	Y/Y Change
Revenue	$6.0B	↑ 11.56%
Net Income	$1.4B	↓ 7.85%
Net Profit Margin	23.35%	↓ 4.93%

	FY24	Y/Y Change
Revenue	$5.4B	↓ 9.41%
Net Income	$4.2B	↑ 197.68%
Net Profit Margin	76.75%	↑ 53.4%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Revenue	$1.3B	↑ 5.01%
Net Income	$351.9M	↓ 4.87%
Net Profit Margin	26.46%	↓ 2.75%

	Q2 FY24	Q/Q Change
Revenue	$1.4B	↑ 4.21%
Net Income	$363.7M	↑ 3.35%
Net Profit Margin	26.24%	↓ 0.22%

	Q3 FY24	Q/Q Change
Revenue	$1.4B	↓ 2.27%
Net Income	$3.1B	↑ 744.32%
Net Profit Margin	226.73%	↑ 200.49%

	Q4 FY24	Q/Q Change
Revenue	$1.4B	↑ 2.32%
Net Income	$385.6M	↓ 87.44%
Net Profit Margin	27.83%	↓ 198.9%

	Q1 FY25	Q/Q Change
Revenue	$1.4B	↑ 1.94%
Net Income	$358.0M	↓ 7.16%
Net Profit Margin	25.34%	↓ 2.49%

	Q2 FY25	Q/Q Change
Revenue	$1.5B	↑ 8.46%
Net Income	$329.8M	↓ 7.88%
Net Profit Margin	21.52%	↓ 3.82%

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Profit	$3.2B	↑ 14.0%

	FY20	Y/Y Change
Profit	$3.3B	↑ 2.96%

	FY21	Y/Y Change
Profit	$4.0B	↑ 21.88%

	FY22	Y/Y Change
Profit	$4.2B	↑ 5.21%

	FY23	Y/Y Change
Profit	$4.6B	↑ 9.72%

	FY24	Y/Y Change
Profit	$4.3B	↓ 6.55%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Profit	$1.0B	↑ 2.48%

	Q2 FY24	Q/Q Change
Profit	$1.1B	↑ 4.56%

	Q3 FY24	Q/Q Change
Profit	$1.1B	↑ 0.31%

	Q4 FY24	Q/Q Change
Profit	$1.1B	↑ 0.19%

	Q1 FY25	Q/Q Change
Profit	$1.1B	↑ 1.6%

	Q2 FY25	Q/Q Change
Profit	$1.2B	↑ 7.07%

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Operating Cash Flow	$1.2B	↑ 27.26%
Investing Cash Flow	$-595.8M	↓ 876.79%
Financing Cash Flow	$-115.6M	↓ 89.5%

	FY20	Y/Y Change
Operating Cash Flow	$1.1B	↓ 10.61%
Investing Cash Flow	$-531.1M	↓ 10.86%
Financing Cash Flow	$-486.9M	↑ 321.19%

	FY21	Y/Y Change
Operating Cash Flow	$1.7B	↑ 64.29%
Investing Cash Flow	$-1.7B	↑ 224.33%
Financing Cash Flow	$-356.3M	↓ 26.82%

	FY22	Y/Y Change
Operating Cash Flow	$1.2B	↓ 29.67%
Investing Cash Flow	$252.3M	↓ 114.65%
Financing Cash Flow	$-1.6B	↑ 344.71%

	FY23	Y/Y Change
Operating Cash Flow	$895.8M	↓ 26.47%
Investing Cash Flow	$173.8M	↓ 31.11%
Financing Cash Flow	$-711.0M	↓ 55.13%

	FY24	Y/Y Change
Operating Cash Flow	$542.3M	↓ 39.46%
Investing Cash Flow	$2.3B	↑ 1230.78%
Financing Cash Flow	$-983.0M	↑ 38.26%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Operating Cash Flow	$-53.5M	↓ 139.17%
Investing Cash Flow	$63.1M	↑ 347.52%
Financing Cash Flow	$61.7M	↓ 114.93%

	Q2 FY24	Q/Q Change
Operating Cash Flow	$371.5M	↓ 794.39%
Investing Cash Flow	$124.8M	↑ 97.78%
Financing Cash Flow	$-96.6M	↓ 256.56%

	Q3 FY24	Q/Q Change
Operating Cash Flow	$351.8M	↓ 5.3%
Investing Cash Flow	$2.7B	↑ 2064.82%
Financing Cash Flow	$-976.7M	↑ 911.08%

	Q4 FY24	Q/Q Change
Operating Cash Flow	$280.4M	↓ 20.3%
Investing Cash Flow	$85.3M	↓ 96.84%
Financing Cash Flow	$-258.0M	↓ 73.58%

	Q1 FY25	Q/Q Change
Operating Cash Flow	$280.4M	↑ 0.0%
Investing Cash Flow	$85.3M	↑ 0.0%
Financing Cash Flow	$-258.0M	↑ 0.0%

	Q2 FY25	Q/Q Change
Operating Cash Flow	$290.2M	↑ 3.5%
Investing Cash Flow	$-172.1M	↓ 301.76%
Financing Cash Flow	$52.7M	↓ 120.43%

Edwards Lifesciences Technicals Summary

Sell

Neutral

Buy

Edwards Lifesciences is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Edwards Lifesciences Corp. Vs Peers

Returns

Ratio's

Overview

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Edwards Lifesciences Corp.	1.56%	13.94%	18.31%	-8.29%	-6.98%
Medtronic Plc	3.54%	-1.58%	4.33%	6.43%	-14.68%
Boston Scientific Corp.	-1.21%	0.6%	30.02%	160.56%	149.82%
Stryker Corporation	2.6%	-0.88%	8.84%	92.09%	94.13%
Abbott Laboratories	2.1%	-5.39%	15.7%	29.42%	21.22%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Edwards Lifesciences Corp.	34.03	34.03	4.86	2.5	0.16	0.08	NA	17.94
Medtronic Plc	25.64	25.64	2.16	5.46	0.1	0.05	0.03	37.36
Boston Scientific Corp.	62.8	62.8	1.83	2.98	0.12	0.05	NA	15.14
Stryker Corporation	51.84	51.84	2.23	13.49	0.14	0.08	0.01	55.43
Abbott Laboratories	16.64	16.64	4.17	5.14	0.31	0.07	0.02	29.05

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Edwards Lifesciences Corp.	Buy	$47.8B	-6.98%	34.03	72.96%
Medtronic Plc	Buy	$119.0B	-14.68%	25.64	13.63%
Boston Scientific Corp.	Buy	$156.3B	149.82%	62.8	13.55%
Stryker Corporation	Buy	$149.6B	94.13%	51.84	12.25%
Abbott Laboratories	Buy	$230.9B	21.22%	16.64	32.43%

About Edwards Lifesciences Corp.

Edwards Lifesciences Corporation provides products and technologies to treat advanced cardiovascular diseases in the United States, Europe, Japan, and internationally. The company offers transcatheter heart valve replacement products for minimally invasive replacement of aortic heart valves under the Edwards SAPIEN family of valves system; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases under the PASCAL PRECISION and Cardioband brands. It also provides surgical structural heart solutions, such as aortic surgical valve under the INSPIRIS brand name; INSPIRIS RESILIA aortic valve, which offers RESILIA tissue and VFit technology; KONECT RESILIA, a pre-assembled tissue valve conduit for complex combined procedures; and MITRIS RESILIA valve. The company distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.

Organization	Edwards Lifesciences
Employees	15800
CEO	Mr. Bernard J. Zovighian
Industry	Health Technology

Key Management of Edwards Lifesciences Corp.

Name	Title
Mr. Bernard J. Zovighian	CEO & Director
Mr. Scott B. Ullem	Corporate VP & CFO
Mr. Donald E. Bobo Jr.	Corporate Vice President of Strategy & Corporate Development
Mr. Larry L. Wood	Corporate VP and Group President of TAVR & Surgical Structural Heart
Mr. Jean-Luc Lemercier	Corporate Vice President of Japan, Asia Pacific & Greater China
Mr. Daveen Chopra	Corporate Vice President of Transcatheter Mitral & Tricuspid Therapies
Mr. Andrew M. Dahl	Principal Accounting Officer, Senior VP & Corporate Controller
Dr. Todd J. Brinton FACC, M.D.	Corporate VP of Advanced Technology & Chief Scientific Officer
Mr. Mark Wilterding	Vice President of Investor Relations
Mr. Mark D. Peterson	Corporate VP & General Counsel

Important FAQs about investing in EW Stock from India :

What is Edwards Lifesciences share price today?

Edwards Lifesciences share price today is $81.36 as on August 30, 2025 at 1:29 am IST at the close of the market. Edwards Lifesciences share today touched a day high of $81.51 and a low of $80.74.

What is the 52 week high and 52 week low for Edwards Lifesciences share?

Edwards Lifesciences share touched a 52 week high of $83.00 and a 52 week low of $64.01. Edwards Lifesciences stock price today i.e. August 30, 2025 at 1:29 am IST is closed at $81.36, lower by 1.98% versus the 52 week high.

How to invest in Edwards Lifesciences Stock (EW) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Edwards Lifesciences on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Edwards Lifesciences Shares that will get you 0.0184 shares as per Edwards Lifesciences share price of $81.36 per share as on August 30, 2025 at 1:29 am IST.

What is the minimum amount required to buy Edwards Lifesciences Stock (EW) from India?

Indian investors can start investing in Edwards Lifesciences (EW) shares with as little as ₹88.1475 or $1 (as of September 01, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹881.47 in Edwards Lifesciences stock (as per the Rupee-Dollar exchange rate as on September 01, 2025). Based on Edwards Lifesciences share’s latest price of $81.36 as on August 30, 2025 at 1:29 am IST, you will get 0.1229 shares of Edwards Lifesciences. Learn more about fractional shares .

What are the returns that Edwards Lifesciences has given to Indian investors in the last 5 years?

Edwards Lifesciences stock has given -6.98% share price returns and 20.75% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?